BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19265040)

  • 21. Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy.
    Taniike M; Yamaguchi O; Tsujimoto I; Hikoso S; Takeda T; Nakai A; Omiya S; Mizote I; Nakano Y; Higuchi Y; Matsumura Y; Nishida K; Ichijo H; Hori M; Otsu K
    Circulation; 2008 Jan; 117(4):545-52. PubMed ID: 18195174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
    Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
    Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
    Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
    Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
    J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
    Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
    Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.
    De Windt LJ; Lim HW; Haq S; Force T; Molkentin JD
    J Biol Chem; 2000 May; 275(18):13571-9. PubMed ID: 10788473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload.
    Liu W; Zi M; Chi H; Jin J; Prehar S; Neyses L; Cartwright EJ; Flavell RA; Davis RJ; Wang X
    J Mol Cell Cardiol; 2011 Apr; 50(4):702-11. PubMed ID: 21284947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diacylglycerol kinase zeta rescues G alpha q-induced heart failure in transgenic mice.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Koyama Y; Goto K; Mende U; Kubota I
    Circ J; 2008 Feb; 72(2):309-17. PubMed ID: 18219172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological roles of MKK4 and MKK7: insights from animal models.
    Wang X; Destrument A; Tournier C
    Biochim Biophys Acta; 2007 Aug; 1773(8):1349-57. PubMed ID: 17157936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
    Purcell NH; Wilkins BJ; York A; Saba-El-Leil MK; Meloche S; Robbins J; Molkentin JD
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14074-9. PubMed ID: 17709754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure.
    Galindo CL; Skinner MA; Errami M; Olson LD; Watson DA; Li J; McCormick JF; McIver LJ; Kumar NM; Pham TQ; Garner HR
    BMC Physiol; 2009 Dec; 9():23. PubMed ID: 20003209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.